CB
Chirality Biosciences, Inc.
SEC filingOther · Farmingdale, NY
Amount raised$3.1Msold at filing
Total offering$4.1M$995K still open
Investors in the raise9count reported to the SEC
FiledOct 29, 2025first sale Oct 17, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Arielle GabalskiExecutive Officer, Director
Robert KaytonDirector
Joanna Jennings EagleExecutive Officer
Executive officers, directors and promoters as listed on the Form D.